Home
News
Publications
Pracsys
PharmLine
Primary Care
Secondary Care
DI library
Links
Meet Us
Contact Us
Members

 

 

 

News  on DI-Zone - 20th September 1999

Primary Care Journal Watch NovoRapid approved in EU (20/09/99)

Primary Care Journal Watch  Pfizer sponsor a erectile dysfunction awareness programme (20/09/99)

Primary Care Journal Watch BMA condemn "scandalous" vaccine shortage (20/09/99)

Primary Care Journal Watch Statement on prevention of stroke recurrence (17/09/99)

Primary Care Journal Watch Anastrozole superior to tamoxifen for advance breast cancer in postmenopausal women (17/09/99)

Primary Care Journal Watch Infliximab trial unblinded early (15/09/99)

Primary Care Journal Watch Leflunomide (Arava) approved in EU (14/09/99)

Primary Care Journal Watch UK antibiotics campaign starting soon (14/09/99)

Primary Care Journal Watch EU approves NovoRapid insulin (13/09/99)

Primary Care Journal Watch  Combination treatment with ACE inhibitor and Angiotensin 2 receptor blockers beneficial in heart failure (13/09/99).

Primary Care Journal Watch Enoxaparin reduces risk of venous thromboembolism in acute medical patients (10/09/99)

Primary Care Journal Watch Growth hormone doubles death rate in critically ill patients (10/09/99)

Primary Care Journal Watch First liver failure reports with rosiglitazone (10/09/99)

Primary Care Journal Watch  Millions more now eligible for ACE- inhibitor (10/09/99)

Primary Care Journal Watch  MS Charity gathering evidence to submit to NICE (09/09/99)

Primary Care Journal Watch Pergolide monotherapy effective in patients with early Parkinson's disease (08/09/99)

Primary Care Journal Watch  Alosetron granted priority review status by the FDA for irritable bowel syndrome (07/09/99)

Primary Care Journal Watch  Celecoxib granted priority review status by the FDA for colon polyps (07/09/99)

Primary Care Journal Watch  Glaxo Wellcome to discontinue Wellferon™ (07/09/99)

Primary Care Journal Watch Moxonidine drug trial halted (07/09/99)

Primary Care Journal Watch  The reasons for the shortage of generics in the UK (06/09/99)

Primary Care Journal Watch  HRT uptake varies according to ethnicity (06/09/99)

Primary Care Journal Watch  Zanamavir could cost NHS £115 million in an epidemic year (06/09/99)

Primary Care Journal Watch  31 Viagra associated deaths in the UK (06/09/99)

Primary Care Journal Watch Ramipril reduces cardiovascular morbidity and mortality (03/09/99)

Primary Care Journal Watch  Melatonin has no effect on jetlag (03/09/99)

Primary Care Journal Watch  Spironolactone reduces morbidity and mortality in severe heart failure (03/09/99)

Primary Care Journal Watch More information on ban on importation of single dose vaccines (01/09/99)

New on DI-Zone

go.gif (1206 bytes)PCJW

The 33rd edition of Primary Care Journal Watch is now available.
 
 
 
 

Best  view

800x600

256  colours